Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B-cell lymphoma and predict clinical outcomeBARRANS, Sharon L; CROUCH, Simon; CARE, Matthew A et al.British journal of haematology. 2012, Vol 159, Num 4, pp 441-453, issn 0007-1048, 13 p.Article

Efficient mitochondrial targeting relies on co-operation of multiple protein signals in plantsCHATRE, Laurent; MATHESON, Loren A; JACK, Andrew S et al.Journal of experimental botany. 2009, Vol 60, Num 3, pp 741-749, issn 0022-0957, 9 p.Article

Interleukin 6, tumour necrosis factor α and lymphotoxin polymorphisms in monoclonal gammapathy of uncertain significance and multiple myelomaDRING, Ann M; DAVIES, Faith E; ROLLINSON, Sara J et al.British journal of haematology. 2001, Vol 112, Num 1, pp 249-251, issn 0007-1048Article

Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic LeukemiaRAWSTRON, Andy C; BENNETT, Fiona L; HILLMEN, Peter et al.The New England journal of medicine. 2008, Vol 359, Num 6, pp 575-583, issn 0028-4793, 9 p.Article

Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCLBROWN, Philip J; ASHE, Sally L; LEICH, Ellen et al.Blood. 2008, Vol 111, Num 5, pp 2816-2824, issn 0006-4971, 9 p.Article

The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcomeBARRANS, Sharon L; EVANS, Paul A. S; O'CONNOR, Sheila J. M et al.Clinical cancer research. 2003, Vol 9, Num 6, pp 2133-2139, issn 1078-0432, 7 p.Article

Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantationRAWSTRON, Andy C; DAVIES, Faith E; DASGUPTA, Ranjit et al.Blood. 2002, Vol 100, Num 9, pp 3095-3100, issn 0006-4971, 6 p.Article

Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma : Results of the United Kingdom lymphoma group LY09 trial (ISRCTN97144519)JOHNSON, Peter W. M; RADFORD, John A; RYDER, David et al.Journal of clinical oncology. 2005, Vol 23, Num 36, pp 9208-9218, issn 0732-183X, 11 p.Article

Early prediction of outcome and response to alemtuzumab therapy in chronic lymphocytic leukemiaRAWSTRON, Andy C; KENNEDY, Ben; MORETON, Paul et al.Blood. 2004, Vol 103, Num 6, pp 2027-2031, issn 0006-4971, 5 p.Article

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphomaBARRANS, Sharon L; CARTER, Ian; OWEN, Roger G et al.Blood. 2002, Vol 99, Num 4, pp 1136-1143, issn 0006-4971Article

Monoclonal B lymphocytes with the characteristics of indolent chronic lymphocytic leukemia are present in 3.5% of adults with normal blood countsRAWSTRON, Andy C; GREEN, Michael J; HILLMEN, Peter et al.Blood. 2002, Vol 100, Num 2, pp 635-639, issn 0006-4971Article

Dysregulation of apoptosis in Waldenstrom's macroglobulinemia does not involve nuclear factor kappa B activationLEITCH, Derek; BARRANS, Sharon L; JACK, Andrew S et al.Seminars in oncology. 2003, Vol 30, Num 2, pp 161-164, issn 0093-7754, 4 p.Article

Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansionRAWSTRON, Andy C; YUILLE, Martin R; HOULSTON, Richard S et al.Blood. 2002, Vol 100, Num 7, pp 2289-2291, issn 0006-4971, 3 p.Article

Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapyRAWSTRON, Andy C; KENNEDY, Ben; HILLMEN, Peter et al.Blood. 2001, Vol 98, Num 1, pp 29-35, issn 0006-4971Article

The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cellsRAWSTRON, Andy C; FENTON, James A. L; JACK, Andrew S et al.Blood. 2000, Vol 96, Num 12, pp 3880-3886, issn 0006-4971Article